Torrent Pharmaceuticals Limited (TORNTPHARM): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Torrent Pharmaceuticals Limited, explained in plain English.

• ▪Torrent Pharmaceuticals Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪TORNTPHARM closed at ₹4,580.00 on 29 October 2026.
• ▪Over the past year the shares are up 27.2%, trading between ₹3,532.60 and ₹5,250.00.
• ▪Reported fundamentals show return on equity of 15.65%, a net margin of 12.21%, debt to equity of 76.78.
• ▪Our transparent MaxGrade checklist scores it D (46/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 22.42% with a maximum drawdown of -11.68% and a beta of 0.31 against NIFTY 50.
• ▪Recent coverage: Torrent Pharma Q2 profit falls 9.6% to ₹534 crore, revenue rises 51%

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Ajanta Pharmaceuticals, Alkem Laboratories, Anthem Biosciences, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma

Last traded values from 29 Oct 2026. Market opens at 9:15 IST.